TD PRIVATE CLIENT WEALTH LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1551017
NEW YORK, NY
Position in VRTX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$676,049
-$138,439 QoQ
Shares Held
1,361
-25.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#949
of 1,705 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD PRIVATE CLIENT WEALTH LLC holds $2,695,967 across 45 Biotechnology names. VRTX ranks #3 (25.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,440 | $731,270 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
2,863 | $689,897 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,361 | $676,049 | |
| 4 | GMAB |
Genmab A/S
|
4,376 | $120,208 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
150 | $93,531 | |
| 6 | MRNA |
Moderna, Inc.
|
1,305 | $91,389 | |
| 7 | INSM |
INSMED Inc
|
517 | $55,122 | |
| 8 | ARGX |
Argenx SE
|
28 | $25,977 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $676,049 | 1,361 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $814,488 | 1,824 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $835,542 | 1,843 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $701,427 | 1,791 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $1,833,333 | 4,118 | Shares | Defined | 2025-07-15 | |
| 2025-03-31 | $3,018,004 | 6,225 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $2,503,585 | 6,217 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $6,365,549 | 13,687 | Shares | Defined | 2024-11-18 | |
| 2024-06-30 | $4,777,662 | 10,193 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,357,216 | 12,816 | Shares | Defined | 2024-08-16 | |
| 2023-12-31 | $5,648,040 | 13,881 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $5,249,830 | 15,097 | Shares | Defined | 2024-08-16 | |
| 2023-06-30 | $5,659,416 | 16,082 | Shares | Defined | 2024-08-16 | |
| 2023-03-31 | $5,405,025 | 17,155 | Shares | Defined | 2024-08-16 | |
| 2022-12-31 | $4,364,043 | 15,112 | Shares | Defined | 2024-08-16 | |
| 2022-09-30 | $4,418,669 | 15,261 | Shares | Defined | 2024-08-16 | |
| 2022-06-30 | $4,442,137 | 15,764 | Shares | Defined | 2024-08-16 | |
| 2022-03-31 | $2,874,323 | 11,014 | Shares | Defined | 2024-08-16 | |
| 2021-12-31 | $2,351,037 | 10,706 | Shares | Defined | 2024-08-16 | |
| 2021-09-30 | $2,059,683 | 11,355 | Shares | Defined | 2024-08-16 | |
| 2021-06-30 | $1,460,204 | 7,242 | Shares | Defined | 2024-08-16 | |
| 2021-03-31 | $156,010 | 726 | Shares | Defined | 2024-08-16 | |
| 2020-12-31 | $1,999,200 | 8,459 | Shares | Defined | 2024-08-16 | |
| 2020-09-30 | $2,835,762 | 10,421 | Shares | Defined | 2024-08-16 | |
| 2020-06-30 | $3,006,450 | 10,356 | Shares | Defined | 2024-08-16 | |
| 2020-03-31 | $184,649 | 776 | Shares | Defined | 2024-08-16 | |
| No filing history on record for this holder in this stock. | ||||||